Details

Last Funding Type

Grant

Last Funding Money Raised

$1.05M

Industries

Biotechnology,Health Care,Medical

Founded date

Jan 1, 2016

Number Of Employee

11 - 50

Operating Status

Active

Amberstone Biosciences discovers novel immunotherapies through innovative technologies and creative partnerships.

Amberstone's focus is difficult targets requiring a unique mode-of-action and/or particular functional property, which are otherwise challenging for traditional approaches.

These conventional limitations are overcome via a two-pronged approach. First, we have demonstrated success with our microfluidics-powered AmberFlow drug-discovery platform. Second, our team of experts has keen insights in immuno-oncology and ample experience with single-cell assay biology.